RYTM CIK: 1649904

Rhythm Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.56
FY22:
21.5
FY23:
68.1
FY24:
117
FY25:
170
(positive)
Change from FY21 to FY25
millions USD
FY21:
−170
FY22:
−179
FY23:
−184
FY24:
−266
FY25:
−192
(positive)
Change from FY21 to FY25
millions USD
FY21:
−68.5
FY22:
−174
FY23:
−168
FY24:
−247
FY25:
−174
(positive)
Change from FY21 to FY25
millions USD
FY21:
−69.6
FY22:
−181
FY23:
−184
FY24:
−260
FY25:
−196
(positive)
Change from FY21 to FY25
millions USD
FY21:
−69.6
FY22:
−181
FY23:
−185
FY24:
−261
FY25:
−197

All amounts in millions USD Data sources:SEC EDGARTwelve Data